Latest Biotech News

Merck and Moderna reported late-stage results in August for a personalized mRNA cancer vaccine, with data indicating the approach slowed the return and spread of melanoma when added to existing...

Experts and industry groups said newly implemented pharmaceutical tariffs—up to 100% on patented drugs and inputs—are adding cost and compliance uncertainty for small and mid-sized biotech firms....

A new report details how AI is reshaping biopharma manufacturing strategy—from faster candidate identification to compressed early development timelines and faster facility adaptation. The piece...

A nationwide Belgian randomized trial of 567 patients found that genome sequencing diagnosed 39.8% of developmental disorder cases, outperforming the standard combination of exome sequencing and...

A research update highlights a label-free microfluidic platform combined with YOLOv8 deep learning to enrich and identify rare circulating tumor cells from blood. The system aims to improve...

A multicenter study reports an explainable machine learning model that combines cardiac CT angiography features with clinical data to predict which patients with atrial fibrillation and heart...

CSL will pay $355 million upfront to co-develop Alentis Therapeutics’ anti-fibrosis candidate for kidney and liver indications, with potential future payments up to $1.2 billion. The deal...

A retrospective, multi-institution analysis presented at the 2026 Society for Neuro-Oncology/ASCO CNS Metastases conference reported intracranial activity for tarlatamab in small cell lung cancer...

A new AI system measures how much of the stomach lining endoscopists actually visualize and links those metrics to detection rates for early gastric cancer and precancerous lesions. In a trial...

A machine learning study of 351 breast cancer patients found that MRI radiomics features drawn from both the tumor and peritumoral region improved early prediction of pathological complete...

CSL agreed to pay $355 million upfront to co-develop Alentis Therapeutics’ kidney and liver anti-fibrosis program, with potential future payments of up to $1.2 billion. The deal adds another...

A retrospective multi-institution analysis presented at the 2026 SNO/ASCO CNS Metastases conference reports intracranial responses with tarlatamab in small cell lung cancer patients with brain...

Researchers report that a gut microbial metabolite, indole, worsens brain injury after stroke by acting on immune cells, with the pathway also tied to poorer outcomes in human patients. The study...

A randomized controlled trial found that a calorie-restricted modified MIND diet increased antioxidant capacity and improved energy and emotional well-being in women with type 2 diabetes and...

Researchers combined blockchain-based customer authentication with machine learning ensemble classifiers to detect money laundering with 96.68% accuracy on real-world banking data. The approach...

A two-stage epigenome-wide study in aneurysmal subarachnoid hemorrhage patients evaluates whether an ANGPT1 methylation signal predicts stroke risk after aneurysm rupture. The signal reportedly...

Immunology startup ai3Bio says it is reframing “immune reset” away from depleting pathogenic B cells and toward targeting inflammatory T cells. The company’s initial disease targets are autoimmune...

An analysis of the FDA’s MAUDE database finds that adverse event reports for oral appliances used to treat obstructive sleep apnea are increasing and shifting across categories. The finding...

A nationwide Belgian randomized trial reported that genome sequencing diagnosed 39.8% of developmental disorder cases, outperforming the standard combination of exome sequencing and chromosomal...

Researchers at the Coriell Institute created a publicly available iPSC resource backed by HiFi long-read whole-genome sequencing, pharmacogenomic and HLA annotations, and web-based tools for...